Integra LifeSciences
IART
259 hedge funds and large institutions have $3.96B invested in Integra LifeSciences in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 36 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
31% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 36
25% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 80
23% more capital invested
Capital invested by funds: $3.23B → $3.96B (+$731M)
4% more funds holding
Funds holding: 248 → 259 (+11)
0.56% less ownership
Funds ownership: 83.99% → 83.43% (-0.56%)
58% less call options, than puts
Call options by funds: $7.84M | Put options by funds: $18.5M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$77.3M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$33.3M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$27.1M |
| 4 |
O
OppenheimerFunds
New York
|
-$20.3M |
| 5 |
Morgan Stanley
New York
|
-$9.92M |
IART Hedge Fund Activity: Q1 2019 in Review
259 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2019, worth a combined $3.96B — up 23% from $3.23B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new IART positions and 36 closed out — a net gain of 11 holders — while 100 added to existing stakes and 80 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $35.1M. The largest seller was Fidelity Investments, cutting an estimated $77.3M.
- 259 institutional investors held Integra LifeSciences (IART) as of Q1 2019, up from 248 in Q4 2018.
- Funds reported $3.96B of Integra LifeSciences stock for Q1 2019, up 23% quarter-over-quarter.
- 47 funds opened new Integra LifeSciences positions in Q1 2019 and 36 closed out, a net change of +11 holders.
- The largest Integra LifeSciences buyer in Q1 2019 was Janus Henderson Group, an estimated $35.1M added.
- The largest Integra LifeSciences seller in Q1 2019 was Fidelity Investments, an estimated $77.3M sold.
Based on aggregated 13F filings for Q1 2019.